l(f)r(sh)g2022-04-02 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-cap-Biotin,DMPE-Cap-Biotin؞˵֬ؿخԽY(ji)Ͽصùصף**ݔ
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0009749 | 100mg |
1
|
ԃr(ji) |
Q-0009749 | 250mg |
1
|
ԃr(ji) |
Q-0009749 | 500mg |
1
|
ԃr(ji) |
Q-0009749 | 1g |
1
|
ԃr(ji) |
Q-0009749 | 5g |
1
|
ԃr(ji) |

DMPE-Cap-Biotin
ⶹޢ֬Ҵ-
1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-cap-Biotin
DMPE-Cap-Biotin
؞˵֬
ؿخԽY(ji)Ͽصùص
**ݔ
ӢĄe
D(+)-Biotin
1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)-
cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid
(+)-Biotin
EINECS 200-399-3
Coenzyme R
biotina
(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valeric acid
Rovimix H2
biotine
Rovimix H 2
Vitamin H
1H-Thieno[3,4-d]imidazole-6-pentanoic acid, 3a,4,6,6a-tetrahydro-2-hydroxy-, (3aR,6S,6aS)-
5-[(3aR,6S,6aS)-2-Hydroxy-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-6-yl]pentanoic acid
5-[(3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid
biotin
Meribin
Biotin for system suitability
6SO6U10H04
Lutavit H2
MFCD00005541
86838
XJ9088200
1203
Factor S
MFCD00063872
Biodermatin
D-(+)-Biotin
D-Biotin
Vitamin B7
ȣ98%
bƿb
Ҏ(gu)mgcg(j)e
fSAͨͨ
a(chn)أ
(yng)̣pgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
DSPE-PEG2k-Mannose¶DSPE-PEG2000pegķ10002000,3400,5000 ҂ṩ@(g)a(chn)Ʒ HУҪgӭԃ
-
pgӹٷƼ˾ṩ 4ME 16:0 PC ^N/A N/A Hʹ
-
l(f)r(sh)g2022-04-02 1,2-dilauroyl -sn-glycero-3-phosphoethanolamine-cap-Biotin,DLPE-Cap-Biotin؞˵֬ؿخԽY(ji)Ͽصùص**ݔ
-
l(f)r(sh)g2022-04-02 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-Rhodamine B,_B(bio)ӛĶⶹޢ֬Ҵ